Sujet

Cancer

Latest breakthroughs in cancer research, treatment, and prevention

602 articles

Why Cushing's Tumors Stop Responding to Temozolomide
Cancer Research

Why Cushing's Tumors Stop Responding to Temozolomide

New research reveals how corticotroph pituitary tumors develop resistance to temozolomide through clonal selection of high MGMT-expressing cells.

Article de recherche
19 mai 2026 0
Radiation Therapy Rivals Surgery for Early-Stage Liver Cancer in Largest Study Yet
Cancer Research

Radiation Therapy Rivals Surgery for Early-Stage Liver Cancer in Largest Study Yet

A multinational study of 4,913 patients finds EBRT delivers survival outcomes comparable to surgery and ablation for early hepatocellular carcinoma.

Article de recherche
19 mai 2026 0
Radiation to Metastases Cuts Cancer Progression Risk in Half in Phase II Trial
Cancer Research

Radiation to Metastases Cuts Cancer Progression Risk in Half in Phase II Trial

Adding targeted radiation to standard therapy reduced progression by 46% across multiple cancer types in the EXTEND trial.

Article de recherche
19 mai 2026 0
Chemo-Free HER2+ Breast Cancer Treatment Achieves Excellent 5-Year Survival
Cancer Research

Chemo-Free HER2+ Breast Cancer Treatment Achieves Excellent 5-Year Survival

A randomized trial shows hormone receptor-positive/HER2+ early breast cancer patients had 100% 5-year overall survival with endocrine therapy plus dual HER2 blockade.

Article de recherche
19 mai 2026 0
New Macrocyclic Peptides Selectively Kill Chemotherapy-Resistant Lung Cancer Cells
Cancer Research

New Macrocyclic Peptides Selectively Kill Chemotherapy-Resistant Lung Cancer Cells

Orally bioavailable cyclin A/B RxL inhibitors exploit a cell-cycle vulnerability in small-cell lung cancer and other G1-S-checkpoint-deficient tumors.

Article de recherche
18 mai 2026 0
Cancer's Growth Protein MYC Found to Secretly Repair Chemo-Damaged DNA
Cancer Research

Cancer's Growth Protein MYC Found to Secretly Repair Chemo-Damaged DNA

MYC protein doesn't just fuel tumor growth — it also repairs DNA damage from chemotherapy, revealing a key resistance mechanism.

Communiqué de presse
17 mai 2026 0
Phase I Trial Tests Ipilimumab Added to Chemoradiation for Advanced Cervical Cancer
Cancer Research

Phase I Trial Tests Ipilimumab Added to Chemoradiation for Advanced Cervical Cancer

NCI-sponsored trial evaluates safety and optimal dosing of immune checkpoint blockade following standard chemoradiation in locally advanced cervical cancer.

Essai clinique
17 mai 2026 0
Dual Checkpoint Blockade Plus FOLFOX Chemo Tested in Metastatic Colorectal Cancer
Cancer Research

Dual Checkpoint Blockade Plus FOLFOX Chemo Tested in Metastatic Colorectal Cancer

A Phase 1/2 trial tests whether combining durvalumab, tremelimumab, and FOLFOX chemotherapy can safely boost immune response in mCRC.

Essai clinique
17 mai 2026 0
Leukemic Stem Cells Make Their Own Ketones to Dodge Cell Death
Cancer Research

Leukemic Stem Cells Make Their Own Ketones to Dodge Cell Death

AML stem cells produce BHB via autonomous ketogenesis to block ferroptosis, revealing a targetable metabolic vulnerability in leukemia.

Article de recherche
17 mai 2026 0
New Immune Checkpoint Found as Neutrophils Sabotage Cancer-Fighting T Cells
Cancer Research

New Immune Checkpoint Found as Neutrophils Sabotage Cancer-Fighting T Cells

Scientists identify CD300ld as a key mechanism by which tumor-infiltrating neutrophils silence CD8+ T cells, opening a new immunotherapy target.

Article de recherche
17 mai 2026 0
Combined ctDNA and PSA Testing Predicts Survival in Metastatic Prostate Cancer
Cancer Research

Combined ctDNA and PSA Testing Predicts Survival in Metastatic Prostate Cancer

A prospective cohort study shows combining ctDNA with PSA levels dramatically improves survival prediction in high-volume metastatic prostate cancer patients.

Article de recherche
17 mai 2026 0
Online Mindfulness Program Shows Promise for Gynecological Cancer Patients
Cancer Research

Online Mindfulness Program Shows Promise for Gynecological Cancer Patients

A Swiss feasibility trial tests digital mindfulness-based cancer recovery, tracking psychosocial outcomes, medication use, and biological markers.

Essai clinique
16 mai 2026 0
PreviousPage 11 of 51Next